E Therapeutics (ETX)

 

ETX Share PerformanceMore

52 week high29.9000 02/11/15
52 week low8.9000 20/09/16
52 week change -17.0000 (-64.76%)
4 week volume3,063,583 01/09/16

Latest NewsMore

Issue of Equity and Directors' shareholdings

Notification of an issue of equity shares e.g. offer for subscription/offer for sale/rights issue

e-Therapeutics operating losses rise

e-Therapeutics posts an operating loss of 9.7m for the six months to the end of July (HY15: loss of 5.9m), including 2.1m good...

Half year results

Announcement of half-year/second quarter financial results

Management Update

Miscellaneous medium priority announcements

e-Therapeutics schedules interims

e-Therapeutics, the drug discovery company, will announce its half year results for the six months ended 31 July on 20 Sep...

Notice of Half Year Results

Notification of the date financial results will be published

Holding(s) in Company - Correction

Notification of major interests in shares

Holding(s) in Company

Notification of major interests in shares

Fundamental DataMore

EPS-3.34
Dividend yield0 %

Equity Research (ETX)

edison investment research
e-Therapeutics plc.
19/05/2016
e-Therapeutics’ strategy has evolved, shifting from investment into its proprietary discovery platform to commercialisation of its 12 preclinical assets and the platform itself. Out-licensing and...
edison investment research
e-Therapeutics plc.
18/02/2016
e-Therapeutics’ (ETX) share price fell c 30% on news that the ETS6103 Phase IIb trial as a second-line therapy for major depressive disorder (MDD) failed to meet its primary efficacy endpoint....
edison investment research
e-Therapeutics plc.
12/10/2015
e-Therapeutics' lead assets, ETS2101 (cancer) and ETS6103 (major depressive disorders), are progressing through clinical trials as planned. ETS2101 has completed three Phase Ia trials and has...

Latest discussion posts More

  • Results

    RNS available at company's website. although seems to be missing in III ...
    22-Mar-2016
    nk1999
  • Re: Good news but why?

    RNS out today afternoon. Good operational progress. Not sure if that warrants a steep rise in SP as seen over the last few days, including a further 15% today. But I ...
    26-Feb-2015
    nk1999
  • Re: Good news but why?

    Clearly somebody knows something we don't. Would that be called insider trading I wonder.
    26-Feb-2015
    Actinidia

Users' HoldingsMore

Users who hold E Therapeutics also hold..
LLOYDS GRP.28%
RENEURON28%
ROCKHOPPER21%
ROYAL BANK SCOT17%
XCITE ENERGY17%

Codes & Symbols

ISINGB00B2823H99
SymbolsETX, LSE:ETX, ETX.L, ETX:LN, LON:ETX, XLON:ETX